Answers are grounded in this paper and cite their sources.
Proof-of-concept study demonstrates a microfluidic device delivering real-time intravenous oxygen, suggesting a potential strategy to prevent ventilator-related lung injury in refractory hypoxemia.
SignificanceThe treatment of hypoxemia that is refractory to the current standard of care is time-sensitive and requires skilled caregivers and use of specialized equipment (e.g., extracorporeal membrane oxygenation). Most patients experiencing refractory hypoxemia will suffer organ dysfunction, and death is common in this cohort. Here, we describe a new strategy to stabilize and support patients using a microfluidic device that administers oxygen gas directly to the bloodstream in real time and on demand using a process that we call sequential shear-induced bubble breakup. If successful, the described technology may help to avoid or decrease the incidence of ventilator-related lung injury from refractory hypoxemia.
No takes yet. Share an insight, caveat, or question.
Vutha et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: